Piramal Pharma Limited

NSEI:PPLPHARMA Voorraadrapport

Marktkapitalisatie: ₹389.2b

Piramal Pharma Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur3.8yrs

Recente managementupdates

Recent updates

₹284 - That's What Analysts Think Piramal Pharma Limited (NSE:PPLPHARMA) Is Worth After These Results

Oct 26
₹284 - That's What Analysts Think Piramal Pharma Limited (NSE:PPLPHARMA) Is Worth After These Results

Piramal Pharma (NSE:PPLPHARMA) Takes On Some Risk With Its Use Of Debt

Oct 25
Piramal Pharma (NSE:PPLPHARMA) Takes On Some Risk With Its Use Of Debt

Here's Why Piramal Pharma (NSE:PPLPHARMA) Has A Meaningful Debt Burden

Jul 14
Here's Why Piramal Pharma (NSE:PPLPHARMA) Has A Meaningful Debt Burden

Estimating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Jun 17
Estimating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

We Think That There Are Issues Underlying Piramal Pharma's (NSE:PPLPHARMA) Earnings

May 21
We Think That There Are Issues Underlying Piramal Pharma's (NSE:PPLPHARMA) Earnings

It's A Story Of Risk Vs Reward With Piramal Pharma Limited (NSE:PPLPHARMA)

Mar 26
It's A Story Of Risk Vs Reward With Piramal Pharma Limited (NSE:PPLPHARMA)

Estimating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Feb 28
Estimating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Earnings Update: Here's Why Analysts Just Lifted Their Piramal Pharma Limited (NSE:PPLPHARMA) Price Target To ₹161

Feb 02
Earnings Update: Here's Why Analysts Just Lifted Their Piramal Pharma Limited (NSE:PPLPHARMA) Price Target To ₹161

Calculating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Nov 09
Calculating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Calculating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Aug 11
Calculating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

CEO

Piramal Pharma heeft geen CEO, of we hebben geen gegevens over hen.

Bestuursleden

NaamPositieTenureCompensatieEigendom
Nandini Piramal
Executive Chairperson4.7yrs₹42.02m0.13%
₹ 513.7m
Vivek Valsaraj
President2.8yrs₹24.77mgeen gegevens
Peter DeYoung
CEO of Piramal Global Pharma & Director4.7yrs₹42.40m0.033%
₹ 126.8m
Neeraj Bharadwaj
Non-Executive Director4.1yrsgeen gegevensgeen gegevens
Subramanian Ramadorai
Independent Non-Executive Director3.8yrs₹4.35m0.0020%
₹ 7.8m
Sridhar Gorthi
Independent Non-Executive Director2.7yrs₹4.20mgeen gegevens
Vibha Rishi
Independent Non-Executive Director2.3yrs₹4.25mgeen gegevens
Peter Stevenson
Independent Non-Executive Additional Director2.7yrs₹3.80mgeen gegevens
Jairaj Purandare
Independent Non Executive Director3.8yrs₹4.55mgeen gegevens

3.8yrs

Gemiddelde duur

58yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van PPLPHARMA wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).